Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > BTD Approval Request...???

<< Previous

Bullboard Posts

Next >>

Comment by fredgoodwinsonon Apr 11, 2022 9:23am

203 Views

Post# 34593179

RE:RE:BTD Approval Request...???

Doubtless mutual self-satisfaction all round in respect of the News Releases however infrequent these have become. In contrast the Newsletters (which were pretty much all we got given for so long) could be vague and ambiguous to the point of futility.

Largely cut and paste from the one before on Rutherrin. Now understand that NSCLC will be the sole Clinical Trial indication for starters - whenever that may be?

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing